Serum and blood based biomarkers for lung cancer screening: a systematic review

BACKGROUND: Lung cancer is the second most common cancer and the leading cause of cancer death for both men and women. Although low-dose CT (LDCT) is recommended for lung cancer screening in high-risk populations and may decrease lung cancer mortality, there is a need to improve the accuracy of lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Gavin C. W., Lazare, Kim, Sullivan, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812229/
https://www.ncbi.nlm.nih.gov/pubmed/29439651
http://dx.doi.org/10.1186/s12885-018-4024-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812229/
https://www.ncbi.nlm.nih.gov/pubmed/29439651
http://dx.doi.org/10.1186/s12885-018-4024-3

Ejemplares similares